OM1 Health
Incorrect password
or
Register Your Organization
OM1 Health OM1 Health
Sunrise Medical Group
SC
Dr. Sarah Chen, MD
Panel
Assistant
Dashboard
Assistant
Schedule
Assistant
Clinical
Orders
Results
My Health Risks
One-Pager
Consent Form
Administration
Org Registration
Provider Registration
Manager Registration
Patient Consent
Management
Providers
Patients
Analytics
Management
Analytics
Settings
Settings
Panel Configuration
Screening Settings
Billing & Invoicing
Compliance
Audit Log
Settings
Preferences
Sign Out

Today's Schedule

Wednesday, March 25, 2026  ·  Dr. Sarah Chen, MD  ·  Primary Care — Main Campus

18
Total Patients Today
12
Predictions Available
5
High-Risk Alerts
3
Previously Viewed
Time Patient Name Visit Type Status Panels Available Risk Alerts Actions
8:00 AM Martinez, Roberto
MRN: 4482910		 Annual Wellness ✓ Available
Risk panels
Cardio Metabolic Neuro
Screening panels
T2D CKD
 3 High
8:30 AM Thompson, Janet
MRN: 5519234		 Follow-Up ✓ Available
Risk panels
Cardio Metabolic
Screening panels
T2D
 2 High
9:00 AM Park, David
MRN: 3301874		 New Patient — Not Available — —
9:30 AM Williams, Eleanor
MRN: 7720391		 Annual Wellness ✓✓ Viewed
Risk panels
Cardio
Screening panels
IPF/PPF/ILD
 1 Mod
10:00 AM Nguyen, Michael
MRN: 6610482		 Follow-Up ✓ Available
Risk panels
Metabolic Renal
Screening panels
CKD
 1 High
10:30 AM O'Brien, Catherine
MRN: 8834029		 Follow-Up — Not Available — —
11:00 AM Patel, Anita
MRN: 1192847		 Annual Wellness ✓✓ Viewed
Risk panels
Cardio Metabolic Respiratory
Screening panels
T2D
 —
11:30 AM Garcia, Luis
MRN: 2204819		 New Patient ✓ Available
Risk panels
Neuro
Screening panels
HS
 1 Mod

Orders

Pending and unviewed assessment orders  ·  Dr. Sarah Chen, MD

Order Date Patient Name Visit Type Assessment Panel Status Actions
03/24/2026
2:14 PM		 Thompson, Janet
MRN: 5519234		 Follow-Up Cardio Metabolic ✓ Available — Not Viewed
03/24/2026
10:02 AM		 Martinez, Roberto
MRN: 4482910		 Annual Wellness Cardio Metabolic Neuro ✓ Available — Not Viewed
03/23/2026
4:48 PM		 Garcia, Luis
MRN: 2204819		 New Patient Neuro ⏳ Pending —
03/22/2026
11:21 AM		 Nguyen, Michael
MRN: 6610482		 Follow-Up Metabolic Renal ✓ Available — Not Viewed
03/20/2026
9:05 AM		 Park, David
MRN: 3301874		 New Patient Cardio Metabolic ⏳ Pending —
03/18/2026
3:30 PM		 Chen, Lily
MRN: 9981203		 Annual Wellness Cardio ✓ Available — Not Viewed
03/15/2026
1:12 PM		 Robinson, Mark
MRN: 5567102		 Follow-Up Respiratory ⏳ Pending —
03/12/2026
8:45 AM		 Anderson, Margaret
MRN: 7748210		 Pre-Op TKA Screening
Includes: Joint Insights DVT Infection		 ✓ Available — Not Viewed

Results

All available assessment results  ·  Dr. Sarah Chen, MD

Result Date Patient Name Visit Type Assessment Panel Status Actions
03/24/2026 Thompson, Janet
MRN: 5519234		 Follow-Up Cardio Metabolic ✓ Not Viewed
03/24/2026 Martinez, Roberto
MRN: 4482910		 Annual Wellness Cardio Metabolic Neuro ✓ Not Viewed
03/22/2026 Nguyen, Michael
MRN: 6610482		 Follow-Up Metabolic Renal ✓ Not Viewed
03/19/2026 Williams, Eleanor
MRN: 7720391		 Annual Wellness Cardio ✓✓ Viewed
03/18/2026 Chen, Lily
MRN: 9981203		 Annual Wellness Cardio ✓ Not Viewed
03/14/2026 Patel, Anita
MRN: 1192847		 Annual Wellness Cardio Metabolic Respiratory ✓✓ Viewed
03/10/2026 Garcia, Luis
MRN: 2204819		 New Patient Neuro ✓✓ Viewed

Order Risk Assessment

Martinez, Roberto  ·  MRN: 4482910  ·  DOB: 06/14/1962  ·  Annual Wellness Visit

Select Assessment Tier

Tier 1
Condition-Specific
Single-condition or narrow-cluster assessment. Best for patients with specific clinical concerns.
10–15 min provider time
Tier 2
Organ-System Panel
Multi-condition panels organized by organ system. High value, clinically coherent interpretation.
25–30 min provider time
Tier 3
Comprehensive
Full multi-system risk evaluation spanning all organ systems in a single integrated report.
45–60 min provider time

Select Single Assessment

Select Organ-System Panels

Risk Assessment

Martinez, Roberto  ·  MRN: 4482910  ·  Last Visit: 11/15/2025  ·  Primary Care — Main Campus

Risk Summary
Generated by PhenOM Health Risk Intelligence | March 25, 2026 | Panel: Cardiovascular Health + Metabolic & Endocrine
High-Risk Findings
MI — 5 Year: 15% predicted 5-year risk (69th percentile vs. age/sex-matched population). Key contributing factors: prior MI (2019), persistent hypertension, pre-diabetic glycemic status, BMI 32.
Stroke — 5 Year: 12% predicted 5-year risk (68th percentile). Key contributing factors: uncontrolled hypertension (145/92 mmHg), suboptimal antihypertensive regimen.
Type 2 Diabetes Mellitus: 9% predicted risk (67th percentile). Key contributing factors: HbA1c 6.8%, fasting glucose 118 mg/dL, BMI 32, positive family history.
Moderate-Risk Findings
AFib: 8% predicted risk (55th percentile). Monitoring recommended.
CKD Stage 3A: 7% predicted risk (41st percentile). eGFR stable at 52; microalbuminuria present.
Considerations
1. Increase lisinopril to 20mg daily or add amlodipine 5mg for BP optimization (target <130/80).
2. Initiate metformin 500mg BID for diabetes prevention given pre-diabetic status and cardiovascular risk profile.
3. Comprehensive metabolic panel and lipid panel within 2 weeks.
4. Cardiology referral for annual post-MI evaluation.
5. Renal function monitoring (eGFR + uACR) q6 months.
6. Lifestyle counseling: Mediterranean diet, 150 min/week moderate exercise, weight reduction goal of 5–7%.
Clinical Disclaimer: This assessment represents AI-generated clinical decision support and does not constitute a diagnosis. Risk predictions are statistical estimates based on population models applied to individual patient data. The ordering provider has independently reviewed these results and exercised clinical judgment in their interpretation. Results were discussed with the patient and incorporated into the care plan as clinically appropriate.
Type 2 Diabetes Mellitus E11.9
⚠ High Estimate
9%
150100
67th percentile
HbA1c 6.8% BMI 32 Fasting glucose 118
Clinical Assessment
Patient has elevated HbA1c (6.8%), fasting glucose 118 mg/dL, and BMI 32. Family history positive for T2DM. Recommend lifestyle modification and consider metformin initiation.
Last assessed: 11/15/2024 ↑ +1.2%
Stroke — 5 Year I10
⚠ High Estimate
12%
150100
68th percentile
BP 145/92 Lisinopril 10mg
Clinical Assessment
BP readings consistently 145/92 mmHg over past 3 visits. Currently on lisinopril 10mg daily. May need dose adjustment. Monitor for end-organ effects.
Last assessed: 11/15/2024 ↑ +0.8%
MI — 5 Year I25.10
⚠ High Estimate
15%
150100
69th percentile
Prior MI 2019 Stress echo clear
Clinical Assessment
History of MI 2019, currently stable on optimal medical therapy. Last stress echo 03/2024 showed no ischemia. Continue current regimen, annual cardiology follow-up.
Last assessed: 11/15/2024 → stable
Chronic Kidney Disease Stage 3A N18.3
↗ Moderate Estimate
7%
150100
41st percentile
eGFR 52 BP control Glucose control
Clinical Assessment
eGFR 52 mL/min/1.73m², stable over past year. Microalbuminuria present. Monitor renal function q6 months. Optimize BP and glucose control.
Last assessed: 10/22/2024 ↓ -0.5%
Atrial Fibrillation I48.91
↗ Moderate Estimate
8%
150100
55th percentile
Clinical Assessment
Moderate risk driven by hypertension, age, and prior MI. No history of palpitations. Consider periodic ECG monitoring.
Last assessed: 11/15/2024 → stable
Heart Failure I50.9
✓ Low Estimate
3%
150100
22nd percentile
Clinical Assessment
No signs of heart failure. EF preserved at 58% on last echo. Continue current cardioprotective therapy.
Last assessed: 11/15/2024 → stable

Cross-Condition Risk Interactions

This patient's elevated diabetes risk (pre-diabetic HbA1c) is compounding both cardiovascular and renal risk trajectories. Uncontrolled blood glucose accelerates CKD progression and increases the probability of recurrent MI. Additionally, persistent hypertension (145/92 mmHg) is a shared driver across stroke, MI, AFib, and CKD risk — addressing BP control would simultaneously reduce risk across four of the six assessed conditions. The prior MI history combined with metabolic syndrome creates a multiplicative effect on 5-year cardiovascular event probability.

Considerations

Immediate Actions

  • Consider increasing antihypertensive medication — BP not at goal
  • Initiate metformin for diabetes prevention given elevated HbA1c
  • Order comprehensive metabolic panel and lipid panel
  • Refer to cardiology for annual post-MI follow-up

Ongoing Monitoring

  • Renal function monitoring every 6 months (eGFR + uACR)
  • HbA1c recheck in 3 months after lifestyle intervention
  • Annual stress testing per cardiology recommendation
  • Periodic ECG monitoring for AFib detection

TKA Screening Results

Anderson, Margaret  ·  MRN: 7748210  ·  DOB: 05/22/1958  ·  Pre-Op Visit: 03/12/2026

Screening panel: TKA Screening · Prediction horizon: 1 year for all results
Joint Insights 1-year post-op outlook

How will total knee replacement surgery impact your quality of life?

Select different preoperative radiographic imaging (KL Grades) to adjust chances of benefiting from surgery based on OA severity:

Reset
Benefit1
65%
of patients like you may improve after surgery
No Change or Worse1
35%
of patients like you may stay the same or get worse after surgery
Risk of Complications2
3%
(Avg: 2%)
of patients like you may experience complications after surgery
Survey Range
No symptoms Mild symptoms Moderate symptoms Severe symptoms Extreme symptoms

The result below comes from your answers about your knee symptoms. Explore how your chances of benefiting from surgery can change by clicking on different symptom segments below:

If you experience no knee symptoms, you are not a good fit for knee surgery. Please talk to your provider about non-surgery options to alleviate your symptoms.

1 Based on patient-reported outcomes (KOOS Jr. / OKS) at 12 months post-op, modeled against a cohort matched on age, sex, BMI, KL grade, and baseline symptom severity.
2 1-year incidence of any TKA-related complication (infection, DVT/PE, revision, manipulation under anesthesia, persistent stiffness).
Deep Vein Thrombosis (DVT) I82.40
1-year post-op risk
↗ Moderate
4.2%
150100
62nd percentile vs. TKA cohort
Age 67 BMI 31 Prior VTE: none Mobility: limited
Clinical Assessment
Elevated baseline VTE risk driven by age, BMI, and reduced preoperative mobility. Recommend standard chemoprophylaxis (enoxaparin 40mg SC daily × 14 days) plus early ambulation and IPC sleeves during inpatient stay.
Assessment generated: 03/12/2026
Periprosthetic Joint Infection T84.54
1-year post-op risk
✓ Low
1.1%
150100
34th percentile vs. TKA cohort
HbA1c 6.1% No prior joint infection Non-smoker MRSA: negative
Clinical Assessment
Infection risk is below the TKA cohort median. Continue standard preoperative chlorhexidine wash, intra-op cefazolin within 60 min of incision, and re-dosing per blood loss protocol. Consider HbA1c optimization to <6.5% prior to elective scheduling.
Assessment generated: 03/12/2026
Clinical Disclaimer: These predictions are AI-generated decision support based on the patient's preoperative profile (demographics, comorbidities, imaging, and reported symptoms) and do not constitute a diagnosis or surgical recommendation. The ordering provider should independently review all results and exercise clinical judgment before counseling the patient on surgical candidacy.

Organization Registration

Complete the steps below to register your organization on the PhenOM platform.

1
Organization Profile
2
Admin Account
3
Compliance
4
Billing
5
Integration

Step 1: Organization Profile

Provider Registration

Enroll a new provider under Sunrise Medical Group

Provider Profile

Provider Permissions & Preferences

Panel Ordering Authority
Can order any panel
Default Assessment Tier
Auto-selected when ordering
Standing Orders
Auto-order panels by visit type
Notification Preferences
Suggested Interpretation Style
Auto-Copy to Chart
Requires FHIR write access

Patient Consent

Customize, print, and send the Consent Form and Patient One-Pager to your patients

Consent Form
One-Pager

Customize for your practice

Understanding Your Health Risk Assessment

Powered by PhenOM Health Risk Intelligence

A message from Sunrise Medical Group

At Sunrise Medical Group, we're committed to proactive, personalized care. Dr. Sarah Chen, MD is pleased to offer this AI-powered health risk assessment.

What Is This?

This assessment analyzes information already in your medical chart — labs, vitals, medications, and history — to estimate your risk of developing certain health conditions over the next 3 to 5 years.

How Does It Work?

The PhenOM system securely reviews data already in your electronic health record. No new blood draws or scans are needed.

Is My Data Safe?

Yes. Your health information is processed on a secure, HIPAA-compliant platform, encrypted at all times, and never sold or shared for marketing.

What Does It Cost?

This is an elective service not covered by insurance. Our office will inform you of the exact fee before you decide.

Ask our front desk to schedule your assessment at your next visit.

Sunrise Medical Group  |  (555) 123-4567  |  sunrisemedical.com

PATIENT CONSENT FOR PHENOM HEALTH RISK ASSESSMENT

Service Description

The patient understands that their healthcare provider is offering a PhenOM Health Risk Assessment, an AI-powered clinical decision support service that uses information already in the medical record to generate personalized risk predictions over the next 3 to 5 years.

What This Service Is

A clinical decision support tool that provides the provider with additional information to help guide care. The provider reviews, interprets, and explains results to the patient.

What This Service Is Not

This assessment is NOT a diagnostic test. Results are statistical estimates and should be considered alongside the provider's clinical judgment.

Data Use and Privacy

Patient data is transmitted securely to OM1's HIPAA-compliant platform and is not sold, shared for marketing, or used in any unrelated way. Data is encrypted in transit and at rest.

Cost and Payment

This is an elective service not covered by insurance. The fee is payable at the time of service and is non-refundable once results have been viewed and interpreted.

Signature fields appear on the patient-facing version of this form.

Consent Form

Collect and manage patient consent for PhenOM Health Risk Assessment

PATIENT CONSENT FOR PHENOM HEALTH RISK ASSESSMENT

Service Description

I understand that my healthcare provider is offering me a PhenOM Health Risk Assessment, which is an AI-powered clinical decision support service. This service uses information already in my medical record — including my demographics, diagnoses, medications, laboratory results, and vital signs — to generate personalized risk predictions for developing specific health conditions over the next 3 to 5 years.

What This Service Is

This assessment is a clinical decision support tool that provides my provider with additional information to help guide my care. It uses artificial intelligence to analyze patterns in my existing health data and estimate my statistical risk for certain conditions compared to similar individuals. My provider will review, interpret, and explain the results to me.

What This Service Is Not

This assessment is NOT a diagnostic test. It does not diagnose any disease or condition. A high-risk prediction does not mean I have or will develop a condition, and a low-risk prediction does not guarantee I will not develop a condition. Results are statistical estimates and should be considered alongside my provider's clinical judgment.

Data Use and Privacy

My data is transmitted securely to OM1's HIPAA-compliant platform for processing and is not sold, shared for marketing purposes, or used in any way unrelated to generating my health risk assessment. My data is encrypted in transit and at rest.

Cost and Payment

I understand this is an elective service that is not covered by health insurance. The fee for this assessment is payable at the time of service. This fee is non-refundable once my provider has viewed and interpreted the results.

Assessment Tier Selected

PhenOM Health Risk Assessment

Plain-language educational document provided to patients before electing the assessment

Understanding Your Health Risk Assessment

Powered by PhenOM Health Risk Intelligence

What Is This?

Your provider now offers a health risk assessment powered by advanced AI technology. This assessment analyzes information already in your medical chart — such as your lab results, vital signs, medications, and health history — to estimate your risk of developing certain health conditions over the next 3 to 5 years. Think of it as a personalized health forecast that helps your provider spot potential problems early, when they are most treatable.

How Does It Work?

The PhenOM system securely reviews data already in your electronic health record. No new blood draws, imaging scans, or procedures are needed. The AI compares your health profile against patterns seen in millions of patient records to estimate your individual risk for conditions like heart disease, stroke, diabetes, kidney disease, and more.

What Will My Provider Learn?

For each condition assessed, your provider receives a risk score (your estimated probability), a comparison showing how your risk compares to other people, the key factors driving your risk, and which factors can be changed through lifestyle or medical treatment. Your provider uses these insights alongside their own clinical expertise to build a proactive, personalized care plan for you.

What This Assessment Does NOT Do

This is not a diagnostic test. It does not tell you or your provider that you have a disease. It has not been approved by the FDA. A higher risk score means the patterns in your data are statistically associated with a higher likelihood of developing a condition, but it is not a certainty. Your provider will explain exactly what your results mean for you.

Is My Data Safe?

Yes. Your health information is processed on a secure, HIPAA-compliant platform. Your data is encrypted at all times, is never sold or shared for marketing, and is used solely to generate your health risk assessment.

What Does It Cost?

This is an elective service not covered by insurance. Your provider's office will inform you of the exact fee before you decide. The fee covers both the AI technology platform and your provider's professional time to review and discuss the results with you.

Who Should Consider This?

This assessment is especially valuable if you have a family history of chronic diseases, risk factors like high blood pressure or elevated blood sugar, want a proactive approach to your health, are interested in how multiple health risks may interact, or are due for an annual wellness visit and want a deeper health picture.

Ask your provider or our front desk staff if you have questions about the PhenOM Health Risk Assessment.

[Practice Name]  |  [Phone]  |  [Website]

Organization Dashboard

Sunrise Medical Group  ·  Admin: Dr. Sarah Chen

247
Assessments This Month
$98,800
Patient Fees Collected
$54,340
OM1 Platform Fees Due
12
Active Providers

Provider Utilization — March 2026

ProviderSpecialtyAssessmentsHigh-Risk FlagsTop TierRevenue
Dr. Sarah Chen, MDInternal Medicine4218Tier 2$16,800
Dr. James Miller, DOFamily Medicine3814Tier 2$15,200
Dr. Priya Patel, MDCardiology3522Tier 2$17,500
Maria Santos, NPInternal Medicine289Tier 1$7,000
Dr. Robert Kim, MDEndocrinology3116Tier 2$14,260

Provider Management

Sunrise Medical Group  ·  12 active providers

NameEmailRoleSpecialtyStatusLast LoginActions
Dr. Sarah Chen, MDschen@sunrisemed.orgPhysicianInternal MedicineActive2 hours ago
Dr. James Miller, DOjmiller@sunrisemed.orgPhysicianFamily MedicineActiveYesterday
Dr. Priya Patel, MDppatel@sunrisemed.orgPhysicianCardiologyActive3 hours ago
Maria Santos, NPmsantos@sunrisemed.orgNPInternal MedicineActive1 hour ago
Dr. Robert Kim, MDrkim@sunrisemed.orgPhysicianEndocrinologyActive5 hours ago
Jennifer Walsh, PAjwalsh@sunrisemed.orgPAFamily MedicineActiveYesterday
Dr. Marcus Lee, MDmlee@sunrisemed.orgPhysicianGeriatricsPending—
Dr. Elena Rossi, MDerossi@sunrisemed.orgPhysicianOncologyInactive3 weeks ago

Patient Management

Sunrise Medical Group  ·  1,284 patients

NameMRNDOBSexAssigned ProviderLast AssessmentStatusActions
Martinez, Roberto448291006/14/1962MDr. Chen03/12/2026Consented
Johnson, Linda330187411/02/1958FDr. Miller02/28/2026Consented
Nguyen, David557109204/22/1970MDr. Patel—Needs Consent
Thompson, Mary229847109/30/1955FDr. Chen03/05/2026Consented
Garcia, Carlos669203401/17/1965MSantos, NP03/10/2026Consented
Williams, Diane441928307/03/1949FDr. Kim02/15/2026Consented
Anderson, Paul778234112/19/1972MDr. Miller—Needs Consent
Patel, Anjali551092403/08/1968FDr. Patel03/14/2026Consented
Brown, Michael339817205/26/1960MDr. Chen01/22/2026Consented
Davis, Susan224710908/11/1953FWalsh, PA03/08/2026Consented

Analytics

247
Assessments (MTD)
12
Active Providers
3.2 days
Avg Turnaround
412
Panels Ordered (MTD)

Assessments per Month

Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar

Panel Mix (MTD)

Cardiac 34%
Metabolic 26%
Oncology 18%
Cognitive 14%
Other 8%

Top Providers by Volume — MTD

ProviderSpecialtyAssessmentsPanels OrderedAvg per Patient
Dr. Sarah Chen, MDInternal Medicine42781.86
Dr. James Miller, DOFamily Medicine38641.68
Dr. Priya Patel, MDCardiology35712.03
Dr. Robert Kim, MDEndocrinology31551.77
Maria Santos, NPInternal Medicine28421.50

Billing & Invoicing

Sunrise Medical Group  ·  Account #SMG-04829

$54,340
Current Balance
$18,720
MTD Charges
$42,180
Last Payment (Feb 28)
Tier 2
Current Plan

Invoices

Invoice #DatePeriodAmountStatusActions
INV-2026-0312Mar 31, 2026Mar 2026$54,340Open
INV-2026-0211Feb 28, 2026Feb 2026$42,180Paid
INV-2026-0118Jan 31, 2026Jan 2026$38,910Paid
INV-2025-1207Dec 31, 2025Dec 2025$35,420Paid
INV-2025-1104Nov 30, 2025Nov 2025$31,860Paid
INV-2025-1001Oct 31, 2025Oct 2025$29,540Overdue

Payment Method

VISA
•••• •••• •••• 4242
Exp 09/28
Sunrise Medical Group
Billing contact: Alex Rivera

Audit Log

Sunrise Medical Group  ·  Immutable activity record

to
TimestampUserRoleSourceActionTargetIP
2026-03-21 14:32:04Dr. Sarah ChenProviderUserPatient ViewedMartinez, R. (MRN 4482910)10.42.1.18
2026-03-21 14:18:51Dr. Sarah ChenProviderAssistantOrder PlacedHeart Failure Risk · Martinez, R.10.42.1.18
2026-03-21 13:55:09Alex RiveraAdminAssistantSettings ChangedWorkflow · HFpEF triage path10.42.1.4
2026-03-21 12:41:22Dr. Priya PatelProviderUserPatient ViewedJohnson, L. (MRN 3301874)10.42.1.27
2026-03-21 11:08:17Jordan LeeManagerAssistantStatus Advanced12 patients → Initiated10.42.1.51
2026-03-21 09:14:50Alex RiveraAdminUserProvider AddedDr. Marcus Lee, MD10.42.1.4
2026-03-21 08:47:11Dr. James MillerProviderUserLogin—10.42.1.21
2026-03-20 17:22:38Dr. Robert KimProviderUserPatient ViewedWilliams, D. (MRN 4419283)10.42.1.40
2026-03-20 16:05:14Alex RiveraAdminUserSettings ChangedBilling · Payment Method10.42.1.4
2026-03-20 14:39:02Dr. Sarah ChenProviderUserOrder PlacedOncology Screen · Thompson, M.10.42.1.18
2026-03-20 11:12:45Jordan LeeManagerAssistantOutreach Queued8 patients · Pre-Diabetes10.42.1.51
2026-03-20 09:30:08Alex RiveraAdminUserLogin—10.42.1.4
2026-03-19 18:04:21Dr. Priya PatelProviderUserOrder PlacedCardiac Risk · Patel, A.10.42.1.27
2026-03-19 15:48:55Alex RiveraAdminUserSettings ChangedProvider Override · Dr. Kim10.42.1.4
2026-03-19 10:21:33Dr. Sarah ChenProviderUserLogin—10.42.1.18

Panel Configuration

Configure panel defaults across your organization and per provider

Available Panels
Cardiac Risk
Annual Wellness
Metabolic Panel
Oncology Screening
Cognitive Health

Cardiac Risk — Org Defaults

These defaults apply to every provider in your organization unless overridden below.

Provider Overrides

Providers using "Org default" inherit the settings above. Click Edit to set a custom configuration.

ProviderSpecialtyConfigurationLast ModifiedActions
Dr. Sarah Chen, MDInternal MedicineOrg default—
Dr. James Miller, DOFamily MedicineOrg default—
Dr. Priya Patel, MDCardiologyCustom · Tier 3, LifetimeMar 18, 2026
Maria Santos, NPInternal MedicineOrg default—
Dr. Robert Kim, MDEndocrinologyCustom · No auto-shareMar 19, 2026
Jennifer Walsh, PAFamily MedicineOrg default—

Provider Settings

Personal preferences for Dr. Sarah Chen, MD

Assessment Preferences

Default Assessment Tier
Suggested Interpretation Style
Auto-Copy to Chart
Notifications for New Predictions

Standing Orders

Auto-order panels for specific visit types

Annual Wellness Visit → Tier 2: Cardiovascular + Metabolic
New Patient → Tier 1: Based on chief complaint
Follow-Up Visit → No default

Screening Manager Registration

Enroll as a screening manager for Sunrise Medical Group

Manager Profile

Notification Preferences

New eligible patient alerts
Notify when new patients match a program threshold
Daily outreach digest

Screening Panel

No programs configured — create one in Settings.

Analytics

to

Settings

Recent
Action tiers
Ask Plan Execute

Assistant

Scoped to your role's modules.

Provider tools

⚠️ Payment Notification

Viewing this patient's PhenOM Health Risk Assessment will incur a charge.

PatientMartinez, Roberto (MRN: 4482910)
PanelCardiovascular Health + Metabolic & Endocrine
Assessment TierTier 2: Organ-System Panel
Patient consent status✓ Consent on file
Note: A charge will be generated when you proceed to view the full results. Subsequent views of the same assessment are free. This action cannot be undone.